RxDoctor Payments Data

Stephen Mendelson, MD

Orthopaedic Surgery · Sterling Heights, MINPI 1790775427

Payments from drug & device makers

$78,509in general payments, 2019–2025

Across 118 payments — averaging $665.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bioventus LLC$61K
  • Bioness Inc$7K
  • Zimmer Biomet$5K
  • Orthopediatrics Corp.$1K
  • Heron Therapeutics, Inc.$1K
  • Zimvie Inc.$1K
  • plus $1K from 15 others
$36,936in research payments, 2019–2025

Across 1 payment — averaging $36,936 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bioventus LLC$37K

What the payments were for

  • Consulting fees$16,61730%
  • Speaking & faculty fees$20,30036%
  • Travel & lodging$9,33717%
  • Food & beverage$3,2736%
  • Education$6,58612%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$78,509 in reported general payments places this provider in the 90th percentile of 829 orthopaedic surgery providers in Michigan.

See all orthopaedic surgery providers in Michigan

Medicare billing

Part B allowed, 2024
$218,531
Medicare patients
425
Services billed
3,824

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Potassium19$10,591
Diclofenac Sodium16$10,551
Celecoxib31$1,282
Naproxen29$184

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Sterling Heights

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →